GLSHQ (Gelesis Holdings) Other Stockholders Equity: $0.00 Mil (As of Jun. 2023)


What is Gelesis Holdings Other Stockholders Equity?

Gelesis Holdings GLSHQ -99.00% Other Stockholders Equity is $0.00 Mil as of Jun. 2023.

Gelesis Holdings's Other Stockholders Equity for the quarter that ended in Jun. 2023 was $0.00 Mil.

Gelesis Holdings's quarterly Other Stockholders Equity increased from Dec. 2022 ($-0.00 Mil) to Mar. 2023 ($-0.00 Mil) and increased from Mar. 2023 ($-0.00 Mil) to Jun. 2023 ($0.00 Mil).

Gelesis Holdings's annual Other Stockholders Equity stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil).

Gelesis Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Other Stockholders Equity Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Other Stockholders Equity
0.00 -0.00

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 0.00

Gelesis Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Gelesis Holdings (GLSHQ) has a Other Stockholders Equity of $0.00 Mil as of Jun. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Other Stockholders Equity too high?
Gelesis Holdings' current Other Stockholders Equity is $0.00 Mil.
How does Gelesis Holdings' Other Stockholders Equity compare to RBSH and PPCB?
Gelesis Holdings' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Other Stockholders Equity is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.